Skip to main content

Welcome Mölnlycke!

By Jamie Smith - 1 Jun 2017
Mölnlycke to establish R&D innovation unit in the BioVentureHub

Mölnlycke, a world-leading medical products and solutions company, is establishing an R&D innovation unit in the BioVentureHub at AstraZeneca Gothenburg. The aim is to find new innovative solutions that will benefit both healthcare professionals and patients. 

The agreement was signed by Barry McBride, Executive Vice-President for R&D at Mölnlycke, and Jan-Olof Jacke, President of AstraZeneca Sweden, during the AstraZeneca Exchange 2017 event on May 31.

Read more.


Photo credit: Christophe Eléhn